Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
MS04 - Mesothelioma Genetics and Novel Targets
- Type: Mini Symposia
- Track: Mesothelioma
- Presentations: 5
- Moderators:R.C. Doebele
- Coordinates: 10/28/2013, 14:00 - 15:30, Bayside 104, Level 1
-
+
MS04.0 - N/A - Chair Intro
14:00 - 14:05
- Abstract
No abstract available for this presentation
-
+
MS04.1 - BAP1 Gene Mutation and Mesothelioma Pathogenesis
14:05 - 14:25 | Author(s): A. Napolitano
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MS04.2 - Sequencing the Mesothelioma Genome - Where Are We Now and Where Are We Going?
14:25 - 14:45 | Author(s): R. Bueno
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MS04.3 - New Molecular Targets in Mesothelioma
14:45 - 15:05 | Author(s): R. Stahel
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MS04.4 - Current Clinical Trials of Targeted Therapies
15:05 - 15:25 | Author(s): P. Baas
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO09 - Mesothelioma I
- Type: Mini Oral Abstract Session
- Track:
- Presentations: 14
- Moderators:K. Suzuki
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 204 A+B, Level 2
-
+
MO09.05 - DISCUSSANT
16:35 - 16:45 | Author(s): A.K. Nowak
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO09.10 - Volumetric Response Classification Criteria in Mesothelioma
17:10 - 17:15 | Author(s): S.G. Armato III
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-041 - Optimising regulatory T cell (Treg) depletion in combination with chemotherapy for enhanced anti-tumour immunity
09:30 - 09:30 | Author(s): A.M. Cook
- Abstract
Loading...
-
+
P2.14 - Poster Session 2 - Mesothelioma
- Type: Poster Session
- Track: Mesothelioma
- Presentations: 15
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.14-004 - EORTC and CALGB prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in unselected patients with newly diagnosed malignant mesothelioma
09:30 - 09:30 | Author(s): T. Meniawy
- Abstract
Loading... -
+
P2.14-014 - A Phase 2 Randomized, Double-blind, Placebo-Controlled, Multicenter Study of VS-6063 as Maintenance Therapy in Subjects with Malignant Pleural Mesothelioma which has Not Progressed on at least 4 Cycles of Pemetrexed/Platinum therapy
09:30 - 09:30 | Author(s): M. Keegan
- Abstract
Loading...
-
+
P3.05 - Poster Session 3 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 22
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.05-020 - Strategies for the prevention of mesothelioma in MexTAg mice
09:30 - 09:30 | Author(s): C. Robinson
- Abstract
Loading...
-
+
P3.14 - Poster Session 3 - Mesothelioma
- Type: Poster Session
- Track: Mesothelioma
- Presentations: 14
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.14-010 - Evaluation of Mesothelioma Tumor Thickness Measurement Variability
09:30 - 09:30 | Author(s): A.K. Nowak
- Abstract
Loading...
-
+
MO19 - Lung Cancer Immunobiology
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 13
- Moderators:Y. Sekido
- Coordinates: 10/30/2013, 10:30 - 12:00, Bayside 201 - 203, Level 2
-
+
MO19.03 - The effects of epidermal growth factor (EGFR) receptor inhibitors on the immune system in patients with advanced non-small cell lung cancer (NSCLC)
10:40 - 10:45 | Author(s): T. Meniawy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
